Loss of INI1 is also helpful to differentiate MRT from other primary renal neoplasms with rhabdoid differentiation, including clear cell renal carcinoma, chromophobe cell renal carcinoma, and other malignances in the urinary system [11, 12]. This evidence concerns the gene SMARCB1 and chromophobe renal cell carcinoma.